Raltegravir/Truvada HIV PEP regimen well tolerated with no infections after its use
For study participants, PrEP was an opportunity to save their relationship
Majority of HIV-positive patients in US not receiving regular medical care
Hormonal contraception and HIV risk: no increased risk in South African cohort
A visit from Wandsworth Oasis
